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Abstract— The structure of the major product from reaction of 4-bromo-3-methyl-1-phenylpyrazol-5-one (1) with ethyl cyanoacetate is 
shown, by means of an X-ray crystal structure determination, to be the spirocyclic compound 4, rather than the previously proposed isomer 
3. © 2007 Elsevier Science. All rights reserved 
The chemistry of derivatives of 3-methyl-1-phenylpyrazol-
5-one (Edaravone)1 has been the subject of much study, as 
has that of the N-methyl derivative antipyrine, the first truly 
synthetic pain reliever.2 Recently,3 it was claimed that the 
4-bromo derivative 1 reacted with ethyl cyanoacetate to 
produce, as the major product, the “unusual” 
furanopyrazole 3, supposedly via the intermediacy of the 
symmetrical compound 2 (Scheme 1). We had reason to 
question the validity of this claim and now show 
unambiguously, using X-ray crystallography, that this 
reaction product is actually the spirocyclic isomer 4. 
 
Scheme 1. 
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We have resynthesized this compound,4 which directly 
furnished crystals suitable for single crystal X-ray structure 
determination from the crude reaction mixture. The infrared 
and 1H NMR spectra matched the reported values. It 
crystallizes in the monoclinic space group P21/n, with a 
single molecule in the asymmetric unit.5 Figure 1 shows a 
perspective view of the structure, which reveals that it is 
actually a spiro[(pyrano[2,3-c]pyrazole)-4,4’-pyrazoline], 
rather than the previously proposed structure. This is a 
known heterocyclic ring system that has been previously 
reported in other derivatives of similar pyrazolones.6  
Figure 1. Perspective view of the X-ray structure of 4. 
Thus, the two exchangeable protons in the NMR spectrum 
are associated with the enamino group, rather than imine 
and hydroxyl protons. In the solid state, one of the NH2 
hydrogens is involved in an intramolecular hydrogen bond 
to the adjacent ester carbonyl oxygen, while the other 
participates in an intermolecular hydrogen bond to the 
spiropyrazolidinone oxygen atom of an adjacent molecule 
related by a crystallographic centre of inversion. The 
molecular packing also involves extensive π−π stacking 
interactions between adjacent molecules. 
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Within the structure the pyranopyrazole ring system is 
approximately orthogonal (88.7 o) to the other pyrazole 
ring, as expected for a spiro centre. The planes of the N-
phenyl rings are inclined to the planes of the attached 
pyranopyrazole and pyrazoline rings at angles of 6.8 and 
25.0 o, respectively. These features and the bond lengths 
and angles are similar to those in the only other reported X-
ray crystal structure of this spirocyclic ring system.7 
In retrospect, the formation of this product is not totally 
unexpected as we have previously demonstrated,7 as part of 
a long-standing interest in the chemistry and tautomerism 
of pyrazolones,8 that the product of reaction of 3-methyl-1-
phenylpyrazol-5-one (5) with TCNE is the related 
compound 8, rather than the previously proposed isomer 6, 
formed via the intermediate 7 (Scheme 2). In the present 
case a related mechanism is likely for formation of 4. 
In conclusion, we have shown that the “unusual” major 
product from the reaction of 4-bromo-3-methyl-1-
phenylpyrazol-5-one (1) with ethyl cyanoacetate is actually 
the spirocyclic compound 4, rather than the previously 
proposed isomer 3. 
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